2020 Outcomes - BSW Heart and Vascular Hospital fiscal year 2020 | Page 38

• Rate of long-term follow-up reporting
• Physician attendance at regional quality group meetings
• Quality improvement activities
• Number of VQI registries subscribed , which provides opportunities for learning and improvement
38
Baylor Scott & White Heart and Vascular Hospital – Dallas Vascular Surgery rehabilitation at both the Dallas and Fort Worth locations , the program is called SET for PAD . Benefits of SET for PAD include improvement in functional capacity , decreased pain , increased leg strength , and reduction of additional risks associated with PAD . Patients are encouraged to complete three exercise sessions per week supervised by an exercise therapist over the course of eight to 12 weeks .
For more information about SET for PAD : 214.820.2109 .
Related clinical trial : WISCR – Wound Imaging Study to Gather Clinical References for a Device to Assist Selecting Level-of-Amputation in PAD Patients
Baylor Scott & White Heart and Vascular Hospital - Dallas was an enrolling site for this study that gathered data to train the CADe algorithm to predict ultimate healing status of tissue in the lower extremities of individuals living with PAD . The investigators focused on demonstrating the feasibility of using such an algorithm to accurately predict the location and extent of small vessel disease prior to amputation . Eventually , the investigators expect the DeepView ® imaging device developed by SpectralMD to help reduce the rate of re-amputation in patients with PAD if used for routine assessment of patients prior to amputation . Stephen Hohmann , MD , is the principal investigator . The study remains open and is enrolling patients .
For more information , contact Merielle Boatman , study coordinator : 214.820.2273 .
COMPLEX DIALYSIS ACCESS
Clinical studies and continued research in the area of complex dialysis access is a mainstay for the vascular surgery division . In fiscal year 2020 , vascular surgeons on the hospital ’ s medical staff continued to see an increasing number of referrals from throughout Texas and the greater Southwest region for complex dialysis access procedures . The team continues to support the National Kidney Foundation ’ s “ Fistula First ” initiative with the goal of providing fistulas for the endstage renal disease patient population in concert with the goals of the National Kidney Foundation Kidney Disease Outcomes Quality Initiative ( NKF KDOQI ).
Baylor Scott & White Heart and Vascular Hospital – Dallas was the first site in the US , and Stephen Hohmann , MD , a vascular surgeon on the hospital ’ s medical staff , was the first surgeon to deploy the endovascular fistula system , a new and innovative treatment option for patients with end-stage renal disease ( ESRD ). The system and technology used enables vascular surgeons on the Baylor Scott & White Heart and Vascular Hospital - Dallas medical staff to provide ESRD patients with two additional fistula location options that are less invasive compared to a surgical fistula . Using this approach can help create and maintain AV access for patients on hemodialysis , which is an important expansion of the hospital ’ s complex dialysis access program .
Clinical study : Humanity trial
Together with Humacyte , a biotechnology and regenerative medicine company , vascular surgeons on the medical staff at Baylor Scott & White Heart and Vascular Hospital – Dallas have continued investigational work with human acellular vessel ( HAV ) Phase III clinical study as a conduit for hemodialysis in patients with end-stage renal disease and who are not candidates for a fistula . As a national and international trial site since fiscal year 2019 , Baylor Dallas ’ HUMANITY trial is one of the largest studies of any bioengineered vascular tissues to date . The Dallas site ’ s principal investigator is Stephen Hohmann , MD .
3-STAR RATING : VQI PARTICIPATION
The Vascular Quality Initiative ( VQI ) is a collaboration of regional quality groups designed to improve the quality , safety , effectiveness , and cost of vascular healthcare by collecting and analyzing information . This allows centers and providers to compare their performance to regional and national benchmarks . The VQI is governed by the Society for Vascular Surgeons ( SVS ) Patient Safety Organization ( PSO ), which provides oversight of data sharing arrangements , key outcome and quality measure analyses , and dissemination of information to participating providers .
Published in March 2020 , through the participation of the VQI database , Baylor Scott & White Heart and Vascular Hospital – Dallas received the 2019 VQI Participation Award * in the form of three stars , the highest rating available . VQI centers are eligible to receive up to three “ stars ” depending on the extent of their participation in four categories :

• Rate of long-term follow-up reporting

• Physician attendance at regional quality group meetings

• Quality improvement activities

• Number of VQI registries subscribed , which provides opportunities for learning and improvement

* Per VQI : This award does not represent the quality of care delivered but rather is a measure of VQI participation .